Pitt to launch study of medical marijuana use to ease pain in sickle cell patients

By: Deb Erdley

Finding a way to use medical marijuana to treat sickle cell anemia will be the focus when the University of Pittsburgh School of Medicine launches a new $3 million research program. It’s part of a 10-year agreement with Goodblend Pennsylvania LLC, Pitt’s new affiliate in medical marijuana research.

State officials on Wednesday awarded the eighth and final license for medical marijuana research to the company that is part of Parallel, a privately-held multi-state cannabis company.

Read the full article

Subscribe and stay updated

Receive our latest blog posts by email.

Stay in Touch

medical marijuana, University of Pittsburgh

About Soapbox Group

Our national team includes lawyers and professionals with experience in federal, state and local government with specialists in public policy, law, business, and public affairs. We help clients to anticipate, mitigate, and leverage matters of government through innovative, holistic public policy and regulation strategies.